Diagnosing diseases is basically the frontlines when it comes to fighting against illnesses and how effectively and efficiently this is done will affect how the rest of the battle goes. Unfortunately, diagnosis can be expensive, depending on the disease. Thanks to a new microchip, which can cost only $0.1 to create, this might not be a problem anymore.
The microchip in question was created by a team of engineers from Stanford who published their findings in the Proceedings of the National Academy of Sciences. Not only is the chip tiny, it’s also incredibly inexpensive to produce and can be manufactured at a large scale in a very short period of time.
“For the developing world, point-of-care (POC) diagnostics design must account for limited funds, modest public health infrastructure, and low power availability,” the paper reads. “To address these challenges, here we integrate microfluidics, electronics, and inkjet printing to build an ultra–low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.”
Calling it the FNIP chip, the researchers created the device with three layers of varying expendability. As for how it is used, it’s basically a two-step process. First, the user would need to customize the configuration in order to suit the particular disease that needs to be diagnosed, Futurism reports. Next, the necessary samples for analysis can then be printed onto the top layer of the chip.
So, which diseases can this microchip detect? So far, the researchers tested it to analyze cancer fluid and succeeded. They also used it to diagnose immune cells and was able to pull off similar results as another diagnostic tool that would have cost $100,000 in comparison.
Before anyone gets too excited, however, the researchers are saying that it would take some time before the microchip becomes widely available. There are some hurdles to overcome first, including more tests to see if the platform is even safe to use.


AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility?
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Apple Restores Telegram to App Store After Content Policy Violation 



